Hims & Hers Health, Inc.
Hims & Hers Announces Acquisition of Eucalyptus to Expand Global Footprint
Summary
Hims & Hers Health, Inc. announced on February 19, 2026, that it has entered into a definitive agreement to acquire Eucalyptus, a digital health company operating in Australia, the UK, Germany, Canada, and Japan, for up to $1.15 billion. The acquisition, which is expected to close mid-2026, will be financed through a combination of cash on hand, future operating cash flows, and the option to settle payments in cash or stock. This strategic move is aimed at expanding Hims & Hers' international presence and enhancing its ability to provide personalized healthcare services globally.
Profitelligence Alerts
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement